CAS 140651-18-9 appears in our catalog under these names: Cdk9 Inhibitor II, CAY10574, CAN508/ 100%, CAN508, 99.59%, 4-((3,5-Diamino-1H-pyrazol-4-yl)diazenyl)phenol, 97%. Offered by: TRC, GLPBio, TargetMol, Biosynth, MedChemExpress. Available pack sizes: 100mg, 1mg, 10mg, 5mg, 50mg, 25mg, 200mg, 50 mg.
CAN-508 is a member of the class of pyrazoles that is 1H-pyrazole substituted by amino, (4-hydroxyphenyl)diazenyl, and amino groups at positions 3, 4 and 5, respectively. It is a CDK9 inhibitor (IC50 = 0.35 M) with 38-fold selectivity for CDK9/cyclin T over other CDK/cyclin complexes. It has a role as an antineoplastic agent, an angiogenesis inhibitor, an apoptosis inducer and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is a member of pyrazoles, a member of phenols, an aromatic amine and a monoazo compound.
Source: ChEBI
| Molecular formula | C9H10N6O |
|---|---|
| Molecular weight | 218.22 g/mol |
| IUPAC name | 4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol |
| InChIKey | AYZRKFOEZQBUEA-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC=C1N=NC2=C(NN=C2N)N)O |
Computed by PubChem (NCBI)